Boxer Capital, LLC Amarin Corp Plcuk Transaction History

Boxer Capital, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$3.94 - $5.84 $23.6 Million - $35 Million	-6,000,000 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$4.04 - $5.31 $4.04 Million - $5.31 Million	-1,000,000 Reduced 14.29%	6,000,000 $29.3 Million
Q2 2020 Aug 14, 2020	BUY	$4.78 - $8.26 $22.7 Million - $39.2 Million	4,750,000 Added 211.11%	7,000,000 $48.4 Million
Q1 2020 May 15, 2020	BUY	$4.0 - $21.53 $9 Million - $48.4 Million	2,250,000 New	2,250,000 $9 Million
Q4 2019 Feb 14, 2020	SELL	$13.94 - $24.12 $48.8 Million - $84.4 Million	-3,500,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$13.89 - $23.16 $48.6 Million - $81.1 Million	3,500,000 New	3,500,000 $53.1 Million
Q1 2019 May 15, 2019	SELL	$12.61 - $22.33 $18.9 Million - $33.5 Million	-1,500,000 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$12.41 - $22.98 $2.48 Million - $4.6 Million	200,000 Added 15.38%	1,500,000 $20.4 Million
Q3 2018 Nov 14, 2018	BUY	$2.45 - $16.27 $3.19 Million - $21.2 Million	1,300,000 New	1,300,000 $21.2 Million

176

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $202M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Boxer Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Boxer Capital, LLC with notifications on news.